The use of an axin stabilizer, XAV939, as part of a treatment cocktail also entailing a TGFβ inhibitor (SB431542) and GMT, was shown to substantially improve cardiac function following MI in mice. The gene discussed is AXIN1; the disease is myocardial infarction.